Since CHML was overexpressed in more than 80% HCC tissues examined, activation of CHML–Rab14 axis might be a general oncogenic event in HCC, which provides a potential therapeutic target for HCC metastasis. The gene discussed is CHML; the disease is hepatocellular carcinoma.